Literature DB >> 32944038

Assessment of p16 and Ki67 Immunohistochemistry Expression in Squamous Intraepithelial Lesion with Cytohistomorphological Correlation.

Apurv Ghosh1, Nirupama M1, Nandan Padmanabha1, Hema Kini1.   

Abstract

BACKGROUND &
OBJECTIVE: Cervical cancer is the most common cancer in women worldwide with high mortality, necessitating quicker diagnostic methods. We wish to enhance the existing cervical biopsies of Squamous Intraepithelial Lesions (SIL) using p16 and Ki67 as surrogate markers to assess correlation between its positivity and histological grade of the lesion.
METHODS: Analysis of p16 and Ki67 expression was done on 31 histopathologically diagnosed cases of SILs. Positive expression of p16 was assessed based on a scoring system and compared with histology and cytology. Ki67 expression was studied and the correlation was observed with degree of dysplasia. Twenty cases of chronic cervicitis was assigned to the control group for comparison.
RESULTS: Cases of HSIL showed greater expression of p16 as compared to LSIL. Sensitivity of p16 for HSIL was higher than that for LSIL. The specificity for HSIL and LSIL was 100%. Ki67 expression correlated well with the degree and level of dysplasia with a significant P-value of 0.002.
CONCLUSION: p16 and Ki67 positivity of SILs should point towards further evaluation. The expressions of p16 and Ki67 are useful markers for confirmation of SILs and in predicting HPV infection which can be further confirmed by HPV DNA testing.

Entities:  

Keywords:  HSIL; LSIL; Squamous intraepithelial lesion

Year:  2020        PMID: 32944038      PMCID: PMC7477676          DOI: 10.30699/ijp.2020.112421.2208

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


Introduction

Carcinoma cervix is one of the most common cancers among women worldwide and is the second most frequent type of cancer among Indian women (1). In India, an estimated 67,477 deaths have been attributed to cervical cancer (2). Early detection of the precursor lesions is therefore of paramount importance to reduce the mortality burden of the disease (3). Various screening modalities are being used to identify high risk patients and guide follow up and further management (4). The Papanicolaou (pap) cervical cytology test has been routinely used since 1960 to screen precursor lesions of the cervix and the diagnostic criteria have been updated since the introduction of the Bethesda system of reporting cervical cytology (5). The earlier terminology of cervical intraepithelial neoplasia (CIN) and its categorisation into three groups (CIN 1,2,3) were riddled with interobserver variability (6-8). With the introduction of the two-tiered system to classify precursor lesions as squamous intraepithelial lesion (SIL), high grade or low grade reproducibility improved, but the quest to improve diagnostic accuracy has led to research with various immunohistochemical markers that target the basic mechanism in the pathogenesis of premalignant lesions of the cervix (9,10) The Human papilloma virus (HPV) infection is responsible for SIL and its progression to invasive carcinoma has been well established. The high-risk 'HPV types 16 and 18’ account for the majority of the women being affected (11). In the life cycle of the virus, the expression of oncoproteins E6 and E7 during the “transformation” phase, leads to inhibition of the tumour suppressor proteins p53 and Rb gene. Overproduction of E2F leads to cyclin D1 inhibition and ultimately leading to p16 overexpression in the infected cells (12). The overexpressed p16 can be detected using immunohistochemistry (IHC) and used in improving diagnostic accuracy (12-14). Another such marker is Ki67, which is expressed during active phases of the cell cycle indicating cellular proliferation (12,15). Over the years, a number of markers have been studied alone or in combination to best analyse, precursor lesions of the cervix to improve diagnostic accuracy (9,16,17). In resource poor centres which cater to an economically challenged population, the feasibility of running an entire battery of markers may not be possible (10,18). In this study immunohistochemical expression of p16 and Ki67 were analysed in histologically and cytologically diagnosed cases of squamous intraepithelial lesions, and to correlate its association with high and low-grade lesions.

Materials and Methods

Case Selection A retrospective study was conducted between January 2015 and April 2017. Thirty-one cases were selected with histopathological diagnosis of cervical intraepithelial lesion (CIN 1,2,3) or squamous intraepithelial lesion (HSIL or LSIL). The specimens included hysterectomy specimens, conisation or punch biopsy samples. Tissue blocks with inadequate material, excessive haemorrhage or necrosis were excluded. The Pap smears were obtained for the cases wherever possible. Histopathological examination was performed at the Department of Pathology, at a tertiary centre in coastal region of India. All the H&E slides were reviewed and a diagnosis of either high grade squamous intraepithelial lesion or low grade squamous intraepithelial lesion was assigned, based on the WHO criteria. The corresponding Pap cervical cytology smears were also reviewed wherever possible and the diagnosis was given, according to the Bethesda System of reporting cervical cytology. Twenty cases of histopathologically diagnosed cases of chronic cervicitis were taken as control for p16 and Ki67 immunostaining. Immunohistochemistry The representative H&E section was selected for immunohistochemistry with p16 and Ki67. IHC was performed on formalin-fixed, paraffin-embedded tissue. Counterstaining was done using Meyer’s hematoxylin. Interpretation Positivity for p16 was considered when there was block staining of nuclear, along with or without cytoplasmic staining (19). The degree of intensity of the stain, parabasal involvement, pattern of staining (focal or diffuse), and percentage of positive staining dysplastic cells were analyzed. Each parameter was graded, and a combined score was used to determine positive or negative result using the criteria used by Alshenawy H. et al. (12,20) (Table 1). For p16 expression to be considered positive a total combined score of >3 was required.
Table 1

Immunohistochemistry scoring for p16

p16 immunostaining grade:Score
Percentage of positive cells (%) <5%0
5-49%1
50-80%2
>80%3
Intensity of reaction No reaction0
Weak1
Variable2
Strong3
Cellular reaction pattern No reaction0
Focal1
Diffuse2
Total
Negative (0–3) Positive (4–8)
Ki67 proliferation index is defined as the percentage of Ki67 positive cells. Grade 1+, 2+, and 3+ were given when the Ki67 index was below 5%, 5–30%, and greater than 30%, respectively by observing nuclei of 200 epithelial cells located across the whole epithelial layer in high-power field as used by Alshenawy H. et al. (12). Immunohistochemistry scoring for p16 Statistical Analysis Data analysis was done using SPSS 17 (SPSS Inc., Chicago, Ill. USA); collected data was analysed by both descriptive and inferential methods. Descriptive method such as frequency and percentage were calculated to summarise the data. Sensitivity, specificity, positive predictive value and negative predictive value along with agreement were calculated.

Results

The age of the patients ranged between 28 and 68 years with majority of the patients being below 50 years of age. Majority of the cases of SIL were with parity of 2 or more. Most common clinical presentation was bleeding per vaginum. Of the total 31 cases, 12 were diagnosed as HSIL while 19 were diagnosed as LSIL on histopathology (Figure 1). Corresponding Pap smear was unavailable for 5 cases. The overall absolute correlation between cytology and histopathology was 58.1%. HSIL was under-reported with 6 cases being reported out of 12 histopathologically diagnosed cases. Five ASC-H and one ASCUS assigned cases on cytology were upgraded to HSIL on histopathology. LSIL cases correlated well, with 13 out of 19 cases being assigned on cytology while one ASCUS case being upgraded to LSIL on histology. According to the criteria used by Alshenawy H et al., in the present study, 58.3% (7/12) cases of HSIL showed absolute p16 positivity while 26.3% (5/19) cases of LSIL showed p16 positivity (Figure 2).
Fig 1

a: Low grade squamous intra-epithelial lesion (LSIL) H&E 200X

Fig 2

a:16 positive (score 8) with diffuse strong expression in HSIL

a: Low grade squamous intra-epithelial lesion (LSIL) H&E 200X b: High grade squamous intra-epithelial lesion (HSIL) H&E 100X c: LSIL pap 400X d: HSIL pap 400X a:16 positive (score 8) with diffuse strong expression in HSIL b: p16 positive (score 4) with focal variable expression in HSIL c: p16 positive (score 4) with focal positive expression in LSIL d: Ki-67 grade 2+ in HSIL e: Ki-67 grade 2+ with full thickness expression in HSIL f: Ki-67 negativity in LSIL In the present study a total of 38.7% (12/31) cases of SILs showed absolute p16 positivity. Sensitivity of p16 was 38.7% with 100% specificity for SILs. Positive predictive value was 100% while negative predictive value was 51.3%. Overall agreement between was 62.74. Of 19 negative cases of p16, 4 cases showed absolute negativity with a score ‘0’. While 15 cases had a score of 2 or more. Among all the SIL cases some amount of p16 activity was observed in 87% of the cases. The expression of Ki67 was “grade 1” in 67.7% of the cases with anatomical expression in the respective cases. The Ki67 expression in the middle and superficial third of the epithelium correlated well with the histopathological diagnosis with a P-value of 0.001 and 0.002 respectively. The control group comprising of diagnosed cases of chronic cervicitis showed no expression with p16 and with 5 out of 20 cases showing <5% expression of Ki67 (Tables 2 and 3).
Table 2

p16 immunostain scoring in LSIL and HSIL

p16 immunostainingHSIL n (%)LSIL n (%)Chronic Cx n (%)
Percentage of positive cells (%)0(<5%)5 (41.7%)11(57.9%)20 (100%)
1(5-49%)4(33.3%)6(31.6%)
2 (50-80%)3 (25.0%)2(10.5%)
Intensity of reaction0 (No reaction)1 (8.3%)3 (15.8%)20(100%)
1(Weak)3 (25.0%)10 (52.6%)
2 (Variable)4 (33.3%)4 (21.1%)
3 (Strong)4 (33.3%)2 (10.5%)
Cellular reaction pattern0 (No reaction)1 (8.3%)3 (15.8%)20(100%)
1 (Focal)10 (83.3%)16 (84.2%)
2 (Diffuse)1 (8.3%)0 (0%)
p16 Negative (0–3)01 (8.3%)3 (15.8%)20 (100%)
23 (25.0%)7 (36.8%)
31 (8.3%)4 (21.1%)
Positive (4–8)44(33.3%)2 (10.5%)
50 (0%)2 (10.5%)
62 (16.7%)1(5.3%)
71 (8.3%)0 (0%)
Table 3

Ki-67 grading in HSIL and LSIL

Ki67HSIL n (%)LSIL n (%)Chronic Cx
00(0%)0(0%)16(80%)
1 (<5%)6 (50.0%)15 (78.9%)4(20%)
2 (5-30%)4 (33.3%)4 (21.1%)0(0%)
3 (>30%)2 (16.7%)0 (0%)0(0%)
p16 immunostain scoring in LSIL and HSIL Ki-67 grading in HSIL and LSIL Comparison of p16 and Ki67 expression between various studies and present study

Discussion

Although histopathology remains the gold standard for the diagnosis of SILs, immune-histochemistry can be helpful in limited tissue biopsies and eliminating the interobserver variability. Recently p16 has gained popularity not only in typing the lesion but also in predicting treatment response (21). Several authors have studied p16 expression using different positivity criteria in both preinvasive and invasive squamous carcinomas (22–25). In this present study the grading used for p16 positivity, was proposed by Songkhun V. et al. and later used by Alshenawy H. et al. (12,20). In the present study the sensitivity for HSIL was 58.3% and for LSIL was 26.3%. While other authors found p16 expression to be between 45% and 100% for HSIL and between 10% and 70% for LSILs (26). In the study by Eleuterio J. et al. in 2007, a positive p16 reaction was seen in 92.3% cases and 15.4% cases of HSIL and LSIL respectively (27). Diane M.C. et al. observed 80.9% and 19.36% positivity with p16 in HSIL and LSIL respectively (18). The authors also stated a sensitivity of 86.9% and a specificity of 87.7% with p16 for HSIL (28). Srivastava S. et al. observed 100% positivity for p16 for both LSIL and HSIL (12). Xing Y. et al. observed 24.4% and 87.5% positivity with p16 in LSIL and HSIL respectively (29). In the study by Leite P. et al. p16 positivity observed was 12.8% and 72.1% for LSIL and HSIL respectively. They also observed a significant relation between p16 positivity and recurrence with P-value of 0.018 (30). Comparative analysis of p16 and Ki67 with various recent studies and the present study is depicted in Table 4.
Table 4

Comparison of p16 and Ki67 expression between various studies and present study

ReferencenLSIL
HSIL
np16Ki67np16Ki67
Present study 511951912712
Hebbar et al. ( 13 )2017 501057201619
Alshenawy A et al. ( 8 ) 2014 751546483248
Xing Y. et al. ( 19 ) 2017 95451116403538
Kanthiya K. et al. ( 16 ) 2016 2431061124614846
The degree of dysplasia correlated with Ki67 expression, in most of the cases had grade 1 expression with 33.3% (4/12) cases of HSIL having grade 2 and 16.7% (2/12) cases of HSIL having grade 3 expression of Ki67. It was also observed that Ki67 expression was extending into the superficial third of the epithelial layer while LSIL demonstrated Ki67 expression which was limited to the basal third. These findings were similar to those by Srivastav S. et al. and Hebbar A. et al. (22,23).

Conclusion

All the SILs showed 100% Ki67 expression with a comparatively good expression of p16 in HSIL followed by LSIL. Such cases with positive p16 and high Ki67 expression should be further evaluated for HPV DNA typing as a routine protocol although not performed in the present study. Sensitivity and specificity of p16 expression was low as compared to other studies. HPV infection status with p16 expression were not available due to resource constraints. Although we have considered block positivity for p16 as true positive, a uniform grading criterion for establishing p16 expression would be effective in interpretation with consensus.
  26 in total

1.  Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study.

Authors:  Jordi Genovés; Frances Alameda; Gemma Mancebo; Josep Maria Solé; Beatriz Bellosillo; Belen Lloveras; Silvia Agramunt; Maria Teresa Baró; Mercè Muset; Beatriz Casado; Laia Serrano; Esther Miralpeix; Ramon Carreras
Journal:  Hum Pathol       Date:  2013-12-18       Impact factor: 3.466

2.  Erratum to: Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.

Authors:  Hojung Lee; Hyekyung Lee; Yong Kyun Cho
Journal:  Diagn Pathol       Date:  2017-05-22       Impact factor: 2.644

3.  Immunohistochemical Expression of the Tumor Suppressor Protein p16INK4a in Cervical Adenocarcinoma.

Authors:  José Eleutério; Thiago Silva Lima; Maria do Perpétuo Socorro Cunha; Diane Isabelle Magno Cavalcante; Angélica Maria Holanda Silva
Journal:  Rev Bras Ginecol Obstet       Date:  2017-02-28

4.  Evaluation of the p16 and Ki-67 Biomarkers as Predictors of the Recurrence of Premalignant Cervical Cancer Lesions after LEEP Conization.

Authors:  Paulo Macêdo de Oliveira Leite; Luciene Tafuri; Maria Zélia de Oliveira Costa; Maria Inês de Miranda Lima; Renata Toscano Simões
Journal:  Rev Bras Ginecol Obstet       Date:  2017-02-23

5.  The utility of p16 INK4a and Ki-67 to identify high-grade squamous intraepithelial lesion in adolescents and young women.

Authors:  Diane M Cavalcante; Iara M Linhares; Margarida M L Pompeu; Paulo C Giraldo; José Eleutério
Journal:  Indian J Pathol Microbiol       Date:  2012 Jul-Sep       Impact factor: 0.740

6.  Expression of the p16 and Ki67 in Cervical Squamous Intraepithelial Lesions and Cancer.

Authors:  Kanjana Kanthiya; Jakkapan Khunnarong; Siriwan Tangjitgamol; Napaporn Puripat; Sujitra Tanvanich
Journal:  Asian Pac J Cancer Prev       Date:  2016

7.  Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.

Authors:  Romy van Baars; Heather Griffin; Zhonglin Wu; Yasmina Jay Soneji; Miekel van de Sandt; Rupali Arora; Jacolien van der Marel; Bram Ter Harmsel; Robert Jach; Krzysztof Okon; Hubert Huras; David Jenkins; Wim Quint; John Doorbar
Journal:  Am J Surg Pathol       Date:  2015-11       Impact factor: 6.394

8.  Role of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study.

Authors:  Ankitha Hebbar; Venkataramappa Srinivasa Murthy
Journal:  J Lab Physicians       Date:  2017 Apr-Jun

9.  High expression of ezrin predicts poor prognosis in uterine cervical cancer.

Authors:  Jienan Kong; Yan Li; Shuangping Liu; Haidan Jin; Yongjun Shang; Chengshi Quan; Yulin Li; Zhenhua Lin
Journal:  BMC Cancer       Date:  2013-11-04       Impact factor: 4.430

10.  C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.

Authors:  Weijing Zhang; Jianping Ou; Fangyong Lei; Teng Hou; Shu Wu; Chunhao Niu; Liqun Xu; Yanna Zhang
Journal:  Tumour Biol       Date:  2015-07-29
View more
  2 in total

1.  The value of Ki67 for the diagnosis of LSIL and the problems of p16 in the diagnosis of HSIL.

Authors:  Jixuan Liu; Sanmei Su; Yafang Liu
Journal:  Sci Rep       Date:  2022-05-09       Impact factor: 4.996

2.  Predictive Value of Marker of Proliferation Ki-67 and Cell Cycle Dependent Protein kinase Inhibitor P16INK4a in Cervical Biopsy to Determine Its Biological Behaviour.

Authors:  Usha Sarma; Gokul Chandra Das; Bidula Sarmah
Journal:  Asian Pac J Cancer Prev       Date:  2021-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.